-
公开(公告)号：EP3359563A1
公开(公告)日：2018-08-15
申请号：EP16777681.4
申请日：2016-10-05
申请人： BioNTech Cell & Gene Therapies GmbH , TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
IPC分类号： C07K14/725 , C07K16/28
CPC分类号： C07K14/7051 , A61K2039/5156 , A61K2039/585 , C07K16/28 , C07K16/30 , C07K2317/35 , C07K2317/52 , C07K2317/524 , C07K2317/526 , C07K2317/56 , C07K2317/622 , C07K2317/74 , C07K2319/33
摘要： The present invention generally embraces the treatment of diseases by targeting cells expressing an antigen on the cell surface. In particular the invention relates to recombinant antigen receptors and uses thereof. T cells engineered to express such antigen receptors are useful in the treatment of diseases characterized by expression of one or more antigens bound by the antigen receptors.
-
公开(公告)号：EP3617226A1
公开(公告)日：2020-03-04
申请号：EP19187303.3
申请日：2016-10-05
申请人： BIONTECH CELL & GENE THERAPIES GMBH , TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GGMBH
IPC分类号： C07K14/725 , C07K16/28
摘要： The present invention generally embraces the treatment of diseases by targeting cells expressing an antigen on the cell surface. In particular the invention relates to recombinant antigen receptors and uses thereof. T cells engineered to express such antigen receptors are useful in the treatment of diseases characterized by expression of one or more antigens bound by the antigen receptors.
-
公开(公告)号：EP3359563B1
公开(公告)日：2019-07-31
申请号：EP16777681.4
申请日：2016-10-05
申请人： BIONTECH CELL & GENE THERAPIES GMBH , TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVESITÄT MAINZ GGMBH
IPC分类号： C07K14/725 , C07K16/28
CPC分类号： C07K14/7051 , A61K2039/5156 , A61K2039/585 , C07K16/28 , C07K16/30 , C07K2317/35 , C07K2317/52 , C07K2317/524 , C07K2317/526 , C07K2317/56 , C07K2317/622 , C07K2317/74 , C07K2319/33
摘要： The present invention generally embraces the treatment of diseases by targeting cells expressing an antigen on the cell surface. In particular the invention relates to recombinant antigen receptors and uses thereof. T cells engineered to express such antigen receptors are useful in the treatment of diseases characterized by expression of one or more antigens bound by the antigen receptors.
-
公开(公告)号：EP3359563B8
公开(公告)日：2019-10-02
申请号：EP16777681.4
申请日：2016-10-05
申请人： BIONTECH CELL & GENE THERAPIES GMBH , TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GGMBH
IPC分类号： C07K14/725 , C07K16/28
-
-
-
搜索结果
4 条记录 (耗时 0.017 秒)
